Elicio Therapeutics Inc. (ELTX)
NASDAQ: ELTX
· Real-Time Price · USD
11.76
1.92 (19.51%)
At close: Aug 18, 2025, 10:39 AM
Elicio Therapeutics Revenue
Elicio Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Elicio Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
32
Market Cap
192.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 0 | n/a |
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | -100.00% |
Dec 31, 2021 | 28.31M | +883.06% |
Dec 31, 2020 | 2.88M | +93.68% |
Dec 31, 2019 | 1.49M | -63.09% |
Dec 31, 2018 | 4.03M | -38.78% |
Dec 31, 2013 | 6.58M | -9.82% |
Dec 31, 2012 | 7.3M | n/a |